W Akram, N Garud, R Joshi - Drug discoveries & therapeutics, 2019 - jstage.jst.go.jp
The present review is focused on the prebiotic impact of inulin on the management of the gastrointestinal disorder. Prebiotics can be described as" non-digestible food ingredient …
SC Wei, J Sollano, YT Hui, W Yu… - Expert Review of …, 2021 - Taylor & Francis
Introduction Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease of the colon, characterized by relapsing and remitting symptoms. Although traditionally viewed as …
The pathogenesis of inflammatory bowel disease (IBD) is not well-understood; however, increased and persistent intestinal inflammation, due to inappropriate immune responses …
AD Amarapurkar, DN Amarapurkar, P Rathi… - Indian Journal of …, 2018 - Springer
Introduction Environmental risk factors have been associated with inflammatory bowel disease (IBD). With rising incidence, it is important to know risk factors associated with IBD in …
G Ray - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
There is rising incidence and prevalence of inflammatory bowel disease (IBD) in India topping the Southeast Asian (SEA) countries. The common genes implicated in disease …
R Rajbhandari, S Blakemore, N Gupta… - World Journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND While Crohn's disease has been studied extensively in high-income countries, its epidemiology and care in low and lower-middle income countries (LLMICs) is …
CW Cho, MW You, CH Oh, CK Lee, SK Moon - Gut and Liver, 2022 - ncbi.nlm.nih.gov
Crohn's disease (CD) is a chronic destructive inflammatory bowel disease that affects young people and is associated with significant morbidity. The clinical spectrum and disease …
Y Li, B Chen, X Gao, N Hu, M Huang, Z Ran, Z Liu… - BMC …, 2019 - Springer
Background This study aimed to understand the disease characteristics and treatment outcomes of Crohn's disease (CD) in a real-world setting in China. Methods In this …
D Bandyopadhyay, S Bandyopadhyay, P Ghosh… - Indian Journal of …, 2015 - Springer
Background There is a paucity of reports on extraintestinal manifestations (EIMs) in patients with inflammatory bowel diseases (IBD) from Asia and India. Methods From May 2011 to …